CLVS does not have a great history......watch for hedge funds to short this stock.
November 12, 2012 Among actively traded Colorado-based stocks that declined on the day was Clovis Oncology Inc. (CLVS), down $41.83 percent ($8.99) to close at $12.50. The Boulder biotech disclosed Monday that a pancreatic drug it hoped would lengthen the lives of patients failed to show significant effects among patients in tests.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.